EDTUTC-4 New YorkLog in Sign up

RHHBY
ROCHE HOLDING LTD S/ADR
stockOTCADR

EODOct 2, 2026

52.25USD-0.191%(-0.10)640,792

RHHBY News

Day breaks

01:04 PM EDTRoche nabs European approval of Susvimo for neovascular AMD ·

Seeking Alpha

11:45 AM EDTEuropean Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD) ·

GlobeNewswire Inc.

11:20 AM EDTCue Biopharma plummets on phase 2 data for chronic spontaneous urticaria asset ·

Seeking Alpha

02:55 PM EDTLilly wins full FDA approval for Inluriyo combo in breast cancer ·

Seeking Alpha

09:50 AM EDTMerck, Astra, Roche and Corcept among winners of EU drug recommendations this week ·

Seeking Alpha

08:24 AM EDTSandoz wins Canada nod for generic Ozempic; inks licensing deal for generic Hemlibra ·

Seeking Alpha

07:08 AM EDTTrump administration is said to weigh allowing most pharma licensing deals with China ·

Seeking Alpha

06:45 AM EDTCHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis ·

GlobeNewswire Inc.

04:44 AM EDTBioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried? ·

The Motley Fool

02:30 PM EDTGenentech and Roche Announce Grand Opening of Boston R&D Innovation Center ·

Business Wire

02:30 PM EDTRoche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases ·

GlobeNewswire Inc.

02:21 PM EDTLooming biosimilar void risks $189B in lost U.S. healthcare savings: report ·

Seeking Alpha

07:06 AM EDTRoche succeeds in late-stage study for Lunsumio regimen in follicular lymphoma ·

Seeking Alpha

01:00 AM EDTRoche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study ·

GlobeNewswire Inc.

12:15 PM EDTSolid Biosciences wins new Outperform at RBC on DMD opportunity ·

Seeking Alpha

06:40 AM EDTImmunotherapy Drugs Market 2026: Precision Medicine, Next-Generation Biologics and Expanding Cancer Indications Fuel Growth Opportunities ·

GlobeNewswire Inc.

11:17 AM EDTMRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE ·

Zacks Investment Research

05:56 AM EDTIn Vitro Diagnostics Market ·

GlobeNewswire Inc.

05:52 AM EDTVABYSMO (faricimab) Clinical, Regulatory and Commercial Intelligence Report 2026 ·

GlobeNewswire Inc.

04:41 AM EDTEpigenetics Market Intelligence Report 2026: Strong Demand from Oncology, Precision Medicine, Pharmaceutical Research, and Liquid-Biopsy Development ·

GlobeNewswire Inc.